NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Medicines distributor AmerisourceBergen Corp (ABC.N) said it authorized a special $2.4 billion share repurchase programme to mitigate a possible dilution from the exercise of warrants issued to Walgreens Boots Alliance Inc (WBA.O) in 2013. AmeriSourceBergen, which has already bought back $650 million of shares in 2014 and $1 billion of…

news

Regeneron Pharmaceuticals, Inc. announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to develop, test and manufacture a monoclonal antibody therapy for the treatment of Ebola virus infection. HHS will provide initial funding of approximately $17 million…

news

The California-based BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets. According to a statement issued by BioMarin, the US drugmaker said it will grant Dr Reddy's a non-exclusive licence to its patents…

news

Sandoz, the generics and biosimilars business of Novartis, today officially opened its new cutting-edge biomanufacturing facility called BioInject, at Schaftenau in the Tyrolean Alps in Austria. It is the result of over 150 million euro worth of investment with creation of 100 highly skilled jobs. In attendance at the event…

news

Sun Pharmaceutical Industries Ltd., India’s largest drug maker, has entered into a definitive agreement with Strides Arcolab Ltd. to sell the erstwhile Ranbaxy’s marketing divisions ‘Solus’ and ‘Solus Care’ operating in the central nervous system (CNS) segment in India for Rs.165 crore. Sun Pharma had last year announced the acquisition…

news

U.S. FDA grants Priority Review to sBLA for ofatumumab as maintenance therapy in relapsed CLL (CLL is the most commonly diagnosed adult leukemia in Western countries) Priority Review is an FDA designation for drugs that treat a serious condition and may provide a significant improvement in safety or efficacy. The…

news

Concerned over possible nexus between doctors and pharmaceutical companies, fair trade regulator CCI will soon carry out a detailed study of pharma and healthcare services sector in the national capital region. Public and private hospitals, insurance companies, pharmaceutical firms and their associations, doctors and their associations, among others, would be…

news

Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival rates of cervical cancer patients than standard therapy, validating the technology behind its pipeline of cancer treatments. About 38.5 percent of the patients in a mid-stage study, whose disease had progressed or returned after prior therapy,…

news

The National Institutes of Health on Thursday approved a blueprint for U.S. President Barack Obama's Precision Medicine Initiative and named an NIH insider as interim director of the project, which aims to enroll 1 million volunteers in the next three to four years. The sweeping study, announced in January by…

news

Amgen Inc said it will buy biotechnology company Dezima Pharma B.V., adding another cholesterol drug to its expanding portfolio of treatments for cardiovascular diseases. Amgen said it will pay $300 million in cash for the Netherlands-based company and up to $1.25 billion on meeting certain development and sales milestones. The…